argenx (Euronext & Nasdaq: ARGX) has commenced a tender offer to acquire all outstanding shares of Forte Biosciences, Inc. (Nasdaq ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions